NYT: July 24, 2019. World wide recall of Allergan textured breast implants will reduce risk of cancer but won’t eliminate it, we tell The New York Times.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
Allergan Breast Implants Linked To Cancer Recalled After FDA Request
NBC: July 24, 2019. NCHR president explains to NBC News why recalling Allergan textured breast implants is “an important step” to improve patients’ safety.
Read More »Allergan Recalls Textured Breast Implants Globally Due to Cancer Links
ICIJ: July 24, 2019. Women considering breast implants shouldn’t have to worry that they will cause cancer, NCHR president tells investigative journalists at ICIJ.
Read More »Allergan Recalls Textured Breast Implants Linked to Rare Cancer
Washington Post: July 24, 2019. Allergan finally recalled their biocell textured breast implants because of the evidence that they can cause cancer. We thank the FDA for urging the company to recall these implants and we hope that the delay hasn’t harmed many patients.
Read More »Allergan Recalls Textured Breast Implant Tied to Rare Cancer
ABC Action News: July 24, 2019. NCHR president points out that the removal of Allergan biocell textured breast implants was inevitable because patients had died from lymphoma caused by the implants. Why weren’t they recalled sooner?
Read More »